🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Medication Collaboration Feasibility Study

RecruitingNAAges 60 Years - anyAllNorthwestern University
NCT07742189 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study examines the feasibility and acceptability of a brief medication collaboration intervention among older adults (age 60+) with early-stage dementia or mild cognitive impairment who take multiple medications and their family caregivers. The main aims are to: 1) determine the feasibility and acceptability of the intervention for older adults with early-stage dementia and their family caregivers, and 2) explore the effects of intervention on medication collaboration, medication adherence, and beliefs about dementia and autonomy. In this study, participants will: 1) complete a 15-30-minute baseline interview (by Zoom or phone), 2) participate together in a 45-60-minute virtual intervention led by an interventionist that includes: Assessment of medication responsibilities and beliefs. Education about dementia and medication management. Cognitive restructuring to address beliefs ab

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria for older adults with dementia: 1. Age 60 or older 2. Diagnosis of dementia, Alzhimer's Disease or Mild Cognitive Impairment 3. Quick Dementia Rating Scale Score 2-12 (inclusive of mild cognitive impairment and mild dementia) 4. Taking 3 or more medications 5. Involved with managing their medications 6. Proficient speaking English 7. Capacity to provide consent Inclusion criteria for caregivers include:: 1. Primary family caregiver for the past 3 months 2. Age 18 or older 3. Proficient speaking English Exclusion Criteria: * adults unable to consent
💊

What it tests

  • Medication Collaboration Intervention
📍

Where

1 site
Northwestern University
Chicago, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy